Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes - Wikidata - wikimedia - TriplyDB

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes

http://www.wikidata.org/entity/Q36364761

about

ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65).Monitoring of antigen-specific CD8 T cells in patients with type 1 diabetes treated with antiCD3 monoclonal antibodies Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment.Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients.Incidental CD8 T cell reactivity against caspase-cleaved apoptotic self-antigens from ubiquitously expressed proteins in islets from prediabetic human leucocyte antigen-A2 transgenic non-obese diabetic mice.Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers.Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2K(d) that stimulates CD8 T cells in insulin-dependent diabetes mellitus Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients.Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis.High incidence of glucose intolerance in Vogt-Koyanagi-Harada disease Autoimmune diabetes: ongoing development of immunological intervention strategies targeted directly against autoreactive T cells Antigen-specific therapeutic approaches in Type 1 diabetes The Development and Application of HLA Tetramers in the Detection, Characterization and Therapy of Type 1 Diabetes Mellitus.Antigen targets of type 1 diabetes autoimmunity T-cell libraries allow simple parallel generation of multiple peptide-specific human T-cell clones.The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice.HLA-B7-restricted islet epitopes are differentially recognized in type 1 diabetic children and adults and form weak peptide-HLA complexes.B-cell cross-presentation of autologous antigen precipitates diabetes.The peptide-binding motif for the human transporter associated with antigen processing Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells.Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.Polyunsaturated fatty acids and membrane organization: elucidating mechanisms to balance immunotherapy and susceptibility to infection Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes.Novel autoantigens in type 1 diabetes.Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLA-A*0201 transgenic mice and in human type 1 diabetes.Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice.Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.Detection of GAD65 autoreactive T-cells by HLA class I tetramers in type 1 diabetic patients.Eukaryotic translation initiation factor 5A inhibition alters physiopathology and immune responses in a "humanized" transgenic mouse model of type 1 diabetes.Viruses and cytotoxic T lymphocytes in type 1 diabetes.Type 1 diabetes: etiology, immunology, and therapeutic strategies.The potential of multimer technologies in type 1 diabetes prediction strategies.Pathogenic and regulatory T cells in type 1 diabetes: losing self-control, restoring it, and how to take the temperature.T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives B cells as effectors and regulators of autoimmunity.Prevention and treatment of type 1 diabetes mellitus by the manipulation of invariant natural killer T cells.The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives.

P2860

Q24563069-54612A81-0CE0-4367-B928-795F2EDF9CCA Q30454241-4FEA0F55-7035-4B57-9F0D-6153E8CE2208 Q33637111-684F2D29-B5F7-4BA5-8D2C-BBAF0BF0F64D Q33811836-4481A5FF-1AF9-4B69-A020-B23A278B8274 Q33906726-38AFBFE9-827F-4D6D-8416-1C619A760A81 Q33909053-A0A858D0-EB37-40A9-AFC9-AECD67A8F81D Q33930268-E7908F50-91CC-4D6D-92CA-5921BDF02729 Q34025467-188EDD0F-C104-4237-8C71-CC27D2636FA7 Q34139182-69F20A75-698E-4EAC-891F-6CE10502FFEF Q34234705-7D0EE49E-8917-402A-B147-6D0C3A7BEA36 Q34244112-7DC6D9A4-D732-4C0E-9B29-B52CE5907608 Q35119479-5B24DEA1-0FD8-4EBB-9D14-7F06B0F463AD Q35306889-E3AB9E8A-6FA2-4D9F-BF70-8403AA058E3A Q35612613-18DB16E5-ADA5-4B9E-843F-80A710A6F26B Q35762883-DEBF8D16-451B-411E-A14D-3469295E41CC Q35843637-7E820C6F-3550-4948-AAEA-BEE92267E2C2 Q35852999-4628C096-D7DF-4D90-B7C5-FA1C2928938F Q35908845-829CF768-EAA5-455C-9F14-3AC0E0231582 Q36079920-10758C67-395E-4DAB-9F36-411CF9456845 Q36249736-49D6CCEA-AC49-422B-9AC5-25EA97847A7A Q36339548-F92D680A-6C79-43B9-883E-25129211EBBB Q36365611-BBD363E0-9B47-4BA3-BDE2-92B51ADA1A3E Q36376478-3C9C51AF-B519-4978-9CAA-74E985DF7AC6 Q36508891-F6F97420-6394-4079-91C3-E38940C71F4F Q36741311-9FBA9992-0D33-4567-AB8D-16158336A945 Q36755911-128CF0D6-9C4D-4DAB-A9B5-C916828F3AAE Q36881807-9B893D0C-E179-4848-B18E-EB9D9320C41E Q37066897-16F89E57-DDE1-467C-890C-B26504911876 Q37359669-8FE35DB2-A662-46BE-998E-384D76F5C8E2 Q37384851-031F4EEF-8089-4BC2-B589-C9CD3327743D Q37474056-FDD550E4-3EE3-4C6A-927D-9FC68D5A644B Q37655999-9058ADF1-BAF1-405E-A43E-71C462C8450D Q37823420-8ADE67D1-B849-490F-95CD-13F1380F92D2 Q37830198-F30C3C56-B666-4480-8A6F-41D23EF11CAC Q37838895-F206A14C-4D72-4D22-AD4A-064778BB582C Q37898049-96116657-08E2-48B1-AAF9-32E3E00DE8B9 Q37904710-0894F88A-3D51-4F61-85E4-2626DD690148 Q37995319-2AFA3E2B-01FA-46AC-874D-DA6285AA9318 Q38028844-420AD967-992F-49EE-913A-EA1D95452470 Q38134108-665B60D3-36E5-4059-B2EC-A603B09CFE24

P2860

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes

http://www.wikidata.org/entity/Q36364761

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年学术文章

@wuu

1995年学术文章

@zh-cn

1995年学术文章

@zh-hans

1995年学术文章

@zh-my

1995年学术文章

@zh-sg

1995年學術文章

@yue

1995年學術文章

@zh

1995年學術文章

@zh-hant

name

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes

@ast

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes

@en

type

label

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes

@ast

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes

@en

prefLabel

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes

@ast

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes

@en

P1433

Q36364761-E7D89F23-510F-4F17-9798-0EBCDAD73620

P1476

Q36364761-2D4D01EF-8EF5-4F5E-949B-61FF2B91DB21

P2093

Q36364761-14B8361C-CE7E-4D9F-9059-149D71669EB5

Q36364761-4A625C06-19DA-4EF5-A5A8-B0967F99E7D8

Q36364761-953400A4-531A-4F23-BFE8-0DDFC0E78771

Q36364761-CC32D198-0D01-429D-8958-8A8284FBD636

Q36364761-D1C97098-4B31-4E55-BBEA-EC00E5E191CE

Q36364761-E97C06D4-4B97-4ADA-BF16-1DA1AABABDC4

Q36364761-FB0D520A-1939-49FE-9F9E-4247D791BF30

P2860

Q36364761-0D6C336A-7197-4817-BAC2-0DFCEF15FD70

Q36364761-0DC05177-8736-4778-9D31-858976222631

Q36364761-12205EA2-ACAB-48EA-A993-D68E2AD9FFA8

Q36364761-138249E4-07F5-4942-8826-77060988F2A0

Q36364761-1D755079-7C13-4B17-B937-91490D65862C

Q36364761-2BAA1603-6CAB-49E0-AD1B-71D21813190C

Q36364761-2F89C7B2-7B37-4E34-B8E8-004EAF4F9657

Q36364761-3E0A566B-7549-4661-99DA-932D323BFC35

Q36364761-3F693AC8-425E-4B37-8E3C-3939CA232885

Q36364761-43282C5D-7542-486F-B0E2-FF5288652404

P304

Q36364761-E6B5A418-E40C-4A72-ADD9-A87AAB4ECCAF

P31

Q36364761-BF3CAB04-3384-4654-A39E-71972F8FC39B

P356

Q36364761-24942E3D-2537-48DE-AA76-86142531C07A

P407

Q36364761-4BE7B1C0-8748-4667-9035-85456776879F

P433

Q36364761-E4D31A2E-B740-4348-A4DA-9CA8F46E89AD

P478

Q36364761-12F365C2-869B-4297-8657-0DCE0EF7B264

P50

Q36364761-C1855240-DCCF-4137-8C7B-59D1511A14D0

P577

Q36364761-19CD288B-2A70-4C07-8DB8-96E7A04C342B

P5875

Q36364761-04D1C8E8-940C-49B2-B466-2FC0F1062067

P698

Q36364761-50FB0BB1-2C88-42AE-B70A-68F2EA79B820

P921

Q36364761-43FDBBCD-76BD-4737-9D38-02DEFD9CCD73

P932

Q36364761-991426EB-FAF7-47BB-BFD6-98C0448BDD21

P356

P1433

Journal of Experimental Medicine

P1476

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes

@en

P2093

A M Felix

http://www.w3.org/2001/XMLSchema#string

E Benazzi

http://www.w3.org/2001/XMLSchema#string

F Sinigaglia

http://www.w3.org/2001/XMLSchema#string

G A Spinas

http://www.w3.org/2001/XMLSchema#string

P Panina-Bordignon

http://www.w3.org/2001/XMLSchema#string

R Lang

http://www.w3.org/2001/XMLSchema#string

R M Pastore

http://www.w3.org/2001/XMLSchema#string

P2860

The murine autoimmune diabetes model: NOD and related strains

A sequential model for peptide binding and transport by the transporters associated with antigen processing

Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry.

Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase.

Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.

Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice.

Prevention of autoimmune insulitis in nonobese diabetic mice by expression of major histocompatibility complex class I Ld molecules.

Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture.

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

Protein traffic on the heat shock promoter: parking, stalling, and trucking along.

P304

1923-1927

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.181.5.1923

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

181

http://www.w3.org/2001/XMLSchema#string

P50

Peter M van Endert

P577

1995-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270785143

http://www.w3.org/2001/XMLSchema#string

P698

7722468

http://www.w3.org/2001/XMLSchema#string

P921

P932

2191981

http://www.w3.org/2001/XMLSchema#string